Français Néerlandais Japonais Chinois Allemand Espagnol Portugais

New biopharma start-up at Lille's Institut Pasteur

10 Aug 2016 | Health Nutrition, A region on the move

A revolutionary start-up has just seen the light of day at the Institut Pasteur campus in Lille. Immune InsighT is a biotech business specialized in analyses to confirm new drug candidates are safe. The company harnesses rare expertise to offer a unique services to clients around the world.

Immune InsighT at Lille's Institut Pasteur

Lille's Institut Pasteur is an international pace-setter and a key player in medical research. Over the past fifteen years, a dozen start-ups have been set up on its campus or through its research teams—including Immune InsighT in 2016.

Immune InsighT offers an all-new, high-end method for confirming the safety of new drug candidates designed to treat cancer, transplants, auto-immune system and inflammatory illnesses, and applications in agrifood and the cosmetic industry prior to the launch of clinical tests. This fast-moving young company offers unique services worldwide.

Completing the full range of tests offered by Immune InsighT early on enables client companies to identify the undesirable effects of drug candidates or other molecules on the immune system both reliably and quickly—and to anticipate the potential failure of a long and costly clinical trial well in advance. 

 

Source: Lille's Institut Pasteur

Back to news

News

Verescence: a €60M investment in Hauts-de-France

London-based Stirling Square acquired a stake in the company at the start of the year, invest-ing €122M in the Verescence 2022 project. €60M of this is destined for its historic Mers-les-Bains site in...

Hauts-de-France a winner in first ever Choose France Awards

Hauts-de-France won the prize for “regional attractiveness” at the first ever Choose France Awards, organised by Business France in Paris, on November 21.

All news